Biotage AB (publ) (STO:BIOT)

Market Cap	9.63B
Revenue (ttm)	2.06B
Net Income (ttm)	284.00M
Shares Out	80.05M
EPS (ttm)	3.55
PE Ratio	33.90
Forward PE	35.15
Dividend	1.65 (1.40%)
Ex-Dividend Date	Apr 26, 2024

Volume	267,404
Average Volume	320,839
Open	118.90
Previous Close	117.90
Day's Range	117.80 - 122.70
52-Week Range	104.70 - 202.20
Beta	0.84
RSI	36.15
Earnings Date	Feb 19, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicol...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1969
• Employees: 674
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BIOT

Financial Performance

In 2024, Biotage AB's revenue was 2.06 billion, an increase of 10.42% compared to the previous year's 1.86 billion. Earnings were 284.00 million, an increase of 15.45%.